Samrotamab

(Synonyms: PR-1498487)
Kundenbewertung

Based on 1 Customer Validation

Samrotamab (PR-1498487) is a humanized IgG1-κ chimeric antibody targeting LRRC15. Samrotamab markedly reduces bladder cancer cells viability and inhibits clonogenic growth, migratory and invasive capabilities. Samrotamab significantly increases LRRC15 mRNA level while suppressing SCG5 mRNA expression. Samrotamab can be used for synthesis of ADC ABBV-085.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 96.00%
  • CAS. Nr.: 2052591-32-7
  • Molecular Weight:145.92 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00